BAMCO Inc’s Evolent Health EVH Stock Holding History

BAMCO Inc’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-121,000	Closed	-$3.07M	–	323
2017 Q2	$3.07M	Buy	+121,000	New	+$2.91M	0.02%	249

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

BAMCO Inc's EVH Position: Q3 2017 in Review

BAMCO Inc sold out of Evolent Health (EVH) in Q3 2017, closing a stake of 121,000 shares — an estimated $3.07M sold.

BAMCO Inc first reported a position in EVH in Q2 2017 and held it in 1 quarter. The position peaked at $3.07M in Q2 2017. 166 funds tracked by Wall St. Rank hold EVH as of Q3 2017.

BAMCO Inc reported no remaining Evolent Health position as of Q3 2017 after selling out during the quarter.
BAMCO Inc sold 121,000 Evolent Health shares in Q3 2017, an estimated $3.07M.
BAMCO Inc first reported a position in Evolent Health in Q2 2017 and held it in 1 quarter.
BAMCO Inc's Evolent Health position peaked at $3.07M in Q2 2017.
166 funds tracked by Wall St. Rank held Evolent Health as of Q3 2017.

Based on BAMCO Inc's 13F filing for Q3 2017, filed 15 Nov 2017.